v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash $ 2,640,484 $ 1,120,122
Restricted cash 380,199 377,772
Accounts receivable, net 142,460
Inventories, net 2,171,252 1,997,526
Amount due from a related party 10,000 420,686
Prepayments and other current assets, net 625,477 539,819
Total current assets 5,827,412 4,598,385
Property and equipment, net 1,025 2,228
Investments in life insurance policies 817,470
Deferred initial public offering (“IPO”) costs 639,587
Deferred tax assets 159,704 150,215
Total assets 6,627,728 5,568,298
Current liabilities    
Accounts payable 61,791 277,500
Contract liabilities 14,515
Bank borrowings, current 1,952,104 2,360,402
Income tax payables 19,980
Accrued expenses and other current liabilities 14,655 75,526
Total current liabilities 2,028,550 2,747,923
Bank borrowings, non-current 3,225,899 3,411,887
Total liabilities 5,254,449 6,159,810
Commitments and contingencies
Shareholders’ equity (deficit)    
Ordinary shares ($0.0005 par value, 100,000,000 shares authorized; 22,200,000 and 20,000,000 shares issued and outstanding as of December 31, 2024 and 2023)* [1] 11,100 10,000
Subscription receivable (10,000)
Additional paid-in capital 2,000,182 1,282
Accumulated deficit (638,380) (596,161)
Accumulated other comprehensive income 377 3,367
Total shareholders’ equity (deficit) 1,373,279 (591,512)
Total liabilities and shareholders’ equity (deficit) $ 6,627,728 $ 5,568,298
[1] Shares and per share data are presented on a retroactive basis to reflect the ordinary shares issuance and share split.